CN Patent

CN110396087A — Hpk1激酶抑制剂、制备方法及其应用

Assigned to Zhuhai Woo Biological Science And Technology Co Ltd · Expires 2019-11-01 · 7y expired

What this patent protects

本发明提供一种通式为Ⅰ的化合物或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物或氘代化合物及其制备方法，本发明还提供一种通式为Ⅰ的化合物或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物或氘代化合物作为HPK1激酶抑制剂在预防和/或治疗癌症中的应用。

USPTO Abstract

本发明提供一种通式为Ⅰ的化合物或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物或氘代化合物及其制备方法，本发明还提供一种通式为Ⅰ的化合物或其药学上可接受的盐、立体异构体、酯、前药、溶剂化物或氘代化合物作为HPK1激酶抑制剂在预防和/或治疗癌症中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN110396087A
Jurisdiction
CN
Classification
—
Expires
2019-11-01
Drug substance claim
No
Drug product claim
No
Assignee
Zhuhai Woo Biological Science And Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.